Jpmorgan Chase & CO Ocular Therapeutix, Inc Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 337,831 shares of OCUL stock, worth $3.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
337,831
Previous 189,295 78.47%
Holding current value
$3.95 Million
Previous $1.62 Million 53.22%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$5.93 - $9.08 $880,818 - $1.35 Million
148,536 Added 78.47%
337,831 $2.48 Million
Q4 2024

Feb 12, 2025
BUY
$8.33 - $11.47 $871,734 - $1.2 Million
104,650 Added 123.63%
189,295 $1.62 Million
Q3 2024

Dec 26, 2024
SELL
$6.45 - $9.23 $4,695 - $6,719
-728 Reduced 0.85%
84,645 $736,000
Q3 2024

Nov 08, 2024
SELL
$6.45 - $9.23 $4,695 - $6,719
-728 Reduced 0.85%
84,645 $736,000
Q2 2024

Dec 26, 2024
BUY
$4.2 - $8.69 $3,057 - $6,326
728 Added 0.86%
85,373 $583,000
Q2 2024

Aug 12, 2024
BUY
$4.2 - $8.69 $67,817 - $140,317
16,147 Added 23.33%
85,373 $583,000
Q1 2024

Dec 26, 2024
SELL
$3.85 - $10.93 $59,363 - $168,529
-15,419 Reduced 18.22%
69,226 $629,000
Q1 2024

May 10, 2024
BUY
$3.85 - $10.93 $4,623 - $13,126
1,201 Added 1.77%
69,226 $629,000
Q4 2023

Dec 26, 2024
SELL
$2.08 - $4.52 $34,569 - $75,122
-16,620 Reduced 19.63%
68,025 $303,000
Q4 2023

Feb 12, 2024
BUY
$2.08 - $4.52 $307 - $668
148 Added 0.22%
68,025 $303,000
Q3 2023

Nov 14, 2023
BUY
$3.14 - $5.04 $11,825 - $18,980
3,766 Added 5.87%
67,877 $213,000
Q2 2023

Aug 11, 2023
BUY
$4.6 - $7.64 $781 - $1,298
170 Added 0.27%
64,111 $330,000
Q1 2023

May 18, 2023
BUY
$2.79 - $6.27 $164,688 - $370,105
59,028 Added 1201.47%
63,941 $336,000
Q1 2023

May 11, 2023
SELL
$2.79 - $6.27 $114,920 - $258,261
-41,190 Reduced 89.34%
4,913 $25,000
Q4 2022

Feb 13, 2023
SELL
$2.61 - $4.41 $3,768 - $6,368
-1,444 Reduced 3.04%
46,103 $130,000
Q3 2022

Nov 14, 2022
BUY
$4.09 - $6.5 $13,578 - $21,580
3,320 Added 7.51%
47,547 $198,000
Q2 2022

Aug 11, 2022
SELL
$3.01 - $5.22 $3,091 - $5,360
-1,027 Reduced 2.27%
44,227 $178,000
Q1 2022

May 11, 2022
BUY
$4.83 - $7.35 $40,760 - $62,026
8,439 Added 22.92%
45,254 $224,000
Q4 2021

Feb 10, 2022
BUY
$6.16 - $12.07 $16,927 - $33,168
2,748 Added 8.07%
36,815 $257,000
Q3 2021

Nov 12, 2021
BUY
$9.7 - $14.34 $330,449 - $488,520
34,067 New
34,067 $340,000

Others Institutions Holding OCUL

# of Institutions
204
Shares Held
137M
Call Options Held
743K
Put Options Held
321K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $901M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email